Previous Nav
Net Change on 28-03-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Max Healthcare Institute Ltd.
Divi's Laboratories Ltd.
Cipla Ltd.
Lonza Group
Lupin Ltd.
Mankind Pharma Ltd.
Aether Industries Ltd.
Jupiter Life Line Hospitals Ltd.
Polymedicure Ltd.
Abbott India Ltd.
Krishna Institute of Medical Sciences Ltd.
Ami Organics Ltd.
Fortis Healthcare Ltd.
TREPS
Alkem Laboratories Ltd.
Laurus Labs Ltd.
Aster DM Healthcare Ltd.
Torrent Pharmaceuticals Ltd.
Gland Pharma Ltd.
Rainbow Children's Medicare Ltd.
Aurobindo Pharma Ltd.
Suven Pharmaceuticals Ltd.
Biocon Ltd.
Vijaya Diagnostic Centre Ltd.
Pfizer Ltd.
Akums Drugs & Pharmaceuticals Ltd.
Sanofi Consumer Healthcare India Ltd.
Gufic Biosciences Ltd.
Concord Biotech Ltd.
182 DAY T-BILL 05.06.25
Net Receivable / Payable
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Chemicals
Medical Equipment/Supplies/Accessories
16/03/2018
30/01/2015
04/01/2005
06/09/2004
22/09/2003
Cash
Equity
Sovereign
SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 03-Jul-1999 and currently has an AUM of ₹3,312.89 crore. SBI Healthcare Opportunities Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.
The NAV of SBI Healthcare Opportunities Fund ended up ₹0.59(0.23%)yesterday to ₹259.3034.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai and Pradeep Kesavan.
9th Floor, Crescenzo, C - 38 & 39 G Block, BKC, Bandra (East) Mumbai - 400 051